Does safety testing, the efficacy, phase 1 through 3 trials for particular drugs for pharmaceutical companies. High growth, growing earnings last year at 17%.
Charles River Labs Intl is a American stock, trading under the symbol CRL-N on the New York Stock Exchange (CRL). It is usually referred to as NYSE:CRL or CRL-N
In the last year, 3 stock analysts published opinions about CRL-N. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Charles River Labs Intl.
Charles River Labs Intl was recommended as a Top Pick by on . Read the latest stock experts ratings for Charles River Labs Intl.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Charles River Labs Intl In the last year. It is a trending stock that is worth watching.
On 2023-09-21, Charles River Labs Intl (CRL-N) stock closed at a price of $198.15.
Is undervalued and has been left behind because the market focused on Covid. CRL is in the same sector as Thermo Fisher, a sector that he likes.